Serum IL-17A, IL-18, and SCD25 (IL-2R) in early diagnosis of Kawasaki disease
10.3969/j.issn.1000-3606.2018.05.012
- VernacularTitle:血清IL-17A、IL-18、SCD25(IL-2R)早期诊断川崎病研究
- Author:
Sirui SONG
1
;
Danying ZHU
;
Liqin CHEN
;
Lijian XIE
;
Tingting XIAO
;
Min HUANG
Author Information
1. 上海交通大学附属儿童医院 上海市儿童医院心内科
- Keywords:
Kawasaki disease;
cytokines;
coronary artery lesions
- From:
Journal of Clinical Pediatrics
2018;36(5):367-371
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the acute phase expression of serum cytokines in children with Kawasaki disease (KD) and its association with coronary artery lesions (CALs). Methods Expression of 13 cytokines in serum of 104 KD patients including 11 cases with CALs and 74 febrile control cases admitted to the hospital from October 2016 to March 2017 were retrospectively analyzed. Results Interleukin (IL)-8, IL-1, IL-2, IL-6, IL-10, IL-17A, IL-18, tumor necrotic factor-α and SCD25 (IL-2R) were declined significantly after intravenous immunoglobulin administration (IVIG) in KD patients (all P<0.05). Compared with the fever control group, Pre-IVIG, an IL-17A level ≥ 0.155 pg/mL had a sensitivity of 50% and 93.2% specificity for predicting KD; IL-18 level ≤ 15.43 pg/mL had a sensitivity of 71.2%, and the specificity was 54.1%; SCD25 (IL-2R) ≥ 29475.29 pg/mL had a 65.4% sensitivity and 81.1% specificity for predicting KD. Before IVIG treatment, the level of IL-10 was significantly lower in KD patients with CALs than in those without CALs. Conclusions Determination of various cytokines profile may be helpful for predicting the disease prognosis and targeting treatment strategies in patients with KD.
